Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. Cardiac assist devices are used to support the failing heart which cannot be managed with standard medical therapy. Short-Term Circulatory Support devices are used in patients with refractory cardiogenic shock as a bridge to decision if unresponsive to the first line therapy. GlobalData uses proprietary data and analytics to provide a comprehensive report on the short term circulatory support devices devices market, including market shares of different players within South Korea. Buy the latest report here.
Smarter leaders trust GlobalData
In 2021, GlobalData’s Market Model methodology determined that the leading player in the short term circulatory support devices market in South Korea was Abiomed followed by LivaNova, Getinge, Abbott Laboratories, Teleflex and Berlin Heart.
Intra-Aortic Balloon Pump Catheters, Percutaneous Ventricular Assist Devices and Short-Term External/Paracorporeal Ventricular Assist Devices are covered under this segment. Intra-Aortic Balloon Pump Catheters are catheters used in conjunction with Intra-Aortic Balloon Pumps to assist in improving the cardiac output to meet the oxygen demand of the body. A Percutaneous Ventricular Assist Device (PVAD) is a catheter-based pump that is placed into the heart to assist in improving cardiac output to meet the oxygen demand of the body. A Short-Term External/Paracorporeal Ventricular Assist Device (Short-Term ExVAD) is a device which has a pump placed outside the body.
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the short term circulatory support devices devices market within South Korea was expected to be over $20m in 2021.
For the latest complete market share analysis of short term circulatory support devices device market in South Korea, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
